Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis

被引:129
作者
Sharp, DA [1 ]
Lawrence, DA [1 ]
Ashkenazi, A [1 ]
机构
[1] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA
关键词
D O I
10.1074/jbc.M413962200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Death receptors trigger apoptosis by activating the apical cysteine proteases caspase-8 and -10 within a death-inducing signaling complex (DISC). c-FLIP (cellular FLICE inhibitory protein) is an enzymatically inactive relative of caspase-8 and -10 that binds to the DISC. Two major c-FLIP variants result from alternative mRNA splicing: a short, 26-kDa protein (c-FLIPS) and a long, 55-kDa form (c-FLIPL). The role of c-FLIPS as an inhibitor of death receptor-mediated apoptosis is well established; however, the function of c-FLIPL remains controversial. Although overexpression of transfected c-FLIPL inhibits apoptosis, ectopic expression at lower levels supports caspase-8 activation and cell death. Simultaneous ablation of both c-FLIP variants augments death receptor-mediated apoptosis, but the impact of selective depletion of c-FLIPL on caspase-8 activation and subsequent apoptosis is not well defined. To investigate this, we developed small interfering RNAs that specifically knock down expression of c-FLIPL in several cancer cell lines and studied their effect on apoptosis initiation by Apo2L/TRAIL (Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand). Knockdown of c-FLIPL augmented DISC recruitment, activation, processing, and release of caspase-8, thereby enhancing effector-caspase stimulation and apoptosis. Thus, endogenous c-FLIPL functions primarily as an inhibitor of death receptor-mediated apoptosis.
引用
收藏
页码:19401 / 19409
页数:9
相关论文
共 48 条
[1]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[2]   The short splice form of Casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis [J].
Bin, LH ;
Li, XY ;
Xu, LG ;
Shu, HB .
FEBS LETTERS, 2002, 510 (1-2) :37-40
[3]   Activation of caspases-8 and-10 by FLIPL [J].
Boatright, KM ;
Deis, C ;
Denault, JB ;
Sutherlin, DP ;
Salvesen, GS .
BIOCHEMICAL JOURNAL, 2004, 382 (02) :651-657
[4]   A unified model for apical caspase activation [J].
Boatright, KM ;
Renatus, M ;
Scott, FL ;
Sperandio, S ;
Shin, H ;
Pedersen, IM ;
Ricci, JE ;
Edris, WA ;
Sutherlin, DP ;
Green, DR ;
Salvesen, GS .
MOLECULAR CELL, 2003, 11 (02) :529-541
[5]  
Burns TF, 2001, J BIOL CHEM, V276, P37879
[6]   c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis [J].
Chang, DW ;
Xing, Z ;
Pan, Y ;
Algeciras-Schimnich, A ;
Barnhart, BC ;
Yaish-Ohad, S ;
Peter, ME ;
Yang, XL .
EMBO JOURNAL, 2002, 21 (14) :3704-3714
[7]   Interdimer processing mechanism of procaspase-8 activation [J].
Chang, DW ;
Xing, Z ;
Capacio, VL ;
Peter, ME ;
Yang, XL .
EMBO JOURNAL, 2003, 22 (16) :4132-4142
[8]   Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis [J].
Chawla-Sarkar, M ;
Bae, SI ;
Reu, FJ ;
Jacobs, BS ;
Lindner, DJ ;
Borden, EC .
CELL DEATH AND DIFFERENTIATION, 2004, 11 (08) :915-923
[9]   Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency [J].
Chun, HJ ;
Zheng, LX ;
Ahmad, M ;
Wang, J ;
Speirs, CK ;
Siegel, RM ;
Dale, MK ;
Puck, J ;
Davis, J ;
Hall, CG ;
Skoda-Smith, S ;
Atkinson, TP ;
Straus, SE ;
Lenardo, MJ .
NATURE, 2002, 419 (6905) :395-399
[10]   Cell death: Critical control points [J].
Danial, NN ;
Korsmeyer, SJ .
CELL, 2004, 116 (02) :205-219